Home › Funds › Rosalind Advisors, Inc. › AVIR
Rosalind Advisors, Inc. position in AVIR
ATEA PHARMACEUTICALS INC · Health Care
Rosalind Advisors, Inc. reported holding 1,070,550 shares of AVIR (ATEA PHARMACEUTICALS INC) in its Q2 2026 13F filing — a position valued at US$5.0M, representing 1.85% of its reported portfolio and ranking #16 among its reported holdings. Rosalind Advisors, Inc. has disclosed AVIR holdings in 2 of the last 2 reported quarters, going back to Q1 2026.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How Rosalind Advisors, Inc.'s AVIR position evolved
Rosalind Advisors, Inc. first disclosed a stake in AVIR in Q1 2026 at 1,171,855 shares (US$6.3M). Across 2 filings, Rosalind Advisors, Inc. increased the stake 0 time(s), trimmed it 1 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 1,070,550 shares valued at US$5.0M — a reduction of -101,305 shares quarter over quarter..
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q1 2026 | 1.17M | $6.30M | New |
| Q2 2026 | 1.07M | $4.98M | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About AVIR and 13F data
AVIR (ATEA PHARMACEUTICALS INC) is a Health Care company. 31 other funds we track also report a position in AVIR — the largest reported positions include BML Capital Management, LLC (US$32.3M), TANG CAPITAL MANAGEMENT LLC (US$22.4M), Bain Capital Life Sciences Investors, LLC (US$9.7M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding AVIR
- BML Capital Management, LLC 6.95M sh · $32.33M · Q2 2026
- TANG CAPITAL MANAGEMENT LLC 4.81M sh · $22.39M · Q2 2026
- Bain Capital Life Sciences Investors, LLC 2.08M sh · $9.65M · Q2 2026
- Royal Palms Capital LLC 71.13K sh · $2.82M · Q3 2026
- CM Management, LLC 355.00K sh · $1.65M · Q2 2026
More on Rosalind Advisors, Inc.
FAQ
How long has Rosalind Advisors, Inc. held AVIR?
Rosalind Advisors, Inc. has disclosed AVIR holdings in 2 of the last 2 reported quarters, going back to Q1 2026.
What is Rosalind Advisors, Inc.'s current position in AVIR?
As of Q2 2026, Rosalind Advisors, Inc. holds 1.07M shares of AVIR (ATEA PHARMACEUTICALS INC), valued at $4.98M, representing 1.85% of its reported portfolio and ranking #16.
Has Rosalind Advisors, Inc. been buying or selling AVIR?
In the latest 13F filing (Q2 2026), Rosalind Advisors, Inc. reduced its position in AVIR.
Which other funds hold AVIR?
Other major institutional holders of AVIR include BML Capital Management, LLC, TANG CAPITAL MANAGEMENT LLC, Bain Capital Life Sciences Investors, LLC, among 31 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.